Thousand Oaks, CA, United States of America

Jeonghoon Sun

This inventor holds 41 USPTO granted patents and 19 published patent applications, plus 6 CIPO patents and 11 EPO patents, primarily in Antibody Engineering. Top assignees: Amgen Inc., Celgene Corporation, Alector LLC. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeonghoon Sun. Retrieved from https://idiyas.com/inventor/jeonghoon-sun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 41 (Patent Applications = 19)

% Patents Active = 100.0

CIPO Patents = 6 (Patent Applications = 11)

EPO Patents = 11 (Patent Applications = 26)

Average Co-Inventor Count = 7.0

ph-index = 15

Forward Citations = 752(Granted Patents)

Location History:

Thousan Oaks, CA (US) (2015)
San Diego, CA (US) (2016 - 2021)
Thousand Oaks, CA (US) (2011 - 2023)
Poway, CA (US) (2023)
San Francisco, CA (US) (2022 - 2024)

Company Filing History:

Atara Biotherapeutics, Inc.

patents

5. 1 out of 834,601

Other

patents

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Antibody

Polypeptides

FGF21

Tumor-Selective

Binding Proteins

CD47

Stabilized Receptors

Immunogenicity

Non-Alcoholic Steatohepatitis

Diabetes

Obesity

Thrombopoietic

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12753225 - ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF (2026-10-06),

2. 12630608 - STABILIZED RECEPTOR POLYPEPTIDES AND USES THEREOF (2026-05-19),

3. 12545740 - ENGINEERING OF AN ANTIBODY FOR TUMOR-SELECTIVE BINDING OF CD47 (2026-02-10),

4. 12428488 - Engineering of an antibody for tumor-selective binding of CD47 (2025-09-30),

5. 12084499 - SIRP-α binding proteins and methods of use thereof (2024-09-10),

6. 11987612 - Siglec-9 ECD fusion molecules (2024-05-21),

7. 11840558 - Methods of treating non-alcoholic steatohepatitis using FGF21 mutants (2023-12-12),

8. 11685770 - Stabilized receptor polypeptides and uses thereof (2023-06-27),

9. 11667699 - Anti-MS4A4A antibodies and methods of use thereof (2023-06-06),

10. 11591390 - SIRP-α binding proteins and methods of use thereof (2023-02-28),

11. 11427632 - Antibodies with low immunogenicity and uses thereof (2022-08-30),

12. 11401336 - BCMA-binding antibodies and uses thereof (2022-08-02),

13. 11072640 - Methods of treating non-alcoholic steatohepatitis using FGF21 mutants (2021-07-27),

14. 10428145 - PD-1 binding proteins and methods of use thereof (2019-10-01),

15. 10407487 - Variant activin receptor (2019-09-10),

Title: Inventor Jeonghoon Sun: Revolutionizing Technology in Thousand Oaks

Introduction: Jeonghoon Sun is a visionary inventor based in Thousand Oaks, CA, known for his groundbreaking contributions to the field of technology.

Latest Patents: Jeonghoon Sun holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Jeonghoon Sun has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Jeonghoon Sun has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and knowledge exchange that has led to remarkable advancements in technology.

Conclusion: Jeonghoon Sun's relentless pursuit of innovation and his passion for pushing the boundaries of technology continue to inspire the next generation of inventors and shape the future of technological advancements.

Profile summary based on public USPTO records.